ARKAITZ
CARRACEDO PEREZ
INVESTIGADOR/A DISTINGUIDO/A
Swiss Federal Institute of Technology in Zurich
Zúrich, SuizaPublicaciones en colaboración con investigadoras/es de Swiss Federal Institute of Technology in Zurich (1)
2020
-
CDCP1 overexpression drives prostate cancer progression and can be targeted in vivo
Journal of Clinical Investigation, Vol. 130, Núm. 5, pp. 2435-2450